Inflationary storm clouds will continue to buffet global pharma industry in 2023
Pharmaceutical Technology
JANUARY 16, 2023
The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. Negotiations over these products are expected from October 2023 and run until August 2024. Free Report. What is the Global Healthcare and Pharma Market Q2 Outlook?
Let's personalize your content